Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis
Brian Foster The Eye Associates, Bradenton, FL, USACorrespondence: Brian FosterThe Eye Associates, 6002 Pointe West Blvd, Bradenton, Fl, 34209-5531, USATel +1 941-220-5987Email bfoster@theeyeassociates.comBackground: The dexamethasone 0.4mg intracanalicular insert (Dextenza, Ocular Therapeutix, Bedf...
Guardado en:
Autor principal: | Foster B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/776049e161404cfbb84cf08af52823a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
por: Brooks CC, et al.
Publicado: (2020) -
A Randomized Fellow-Eye Clinical Trial to Evaluate Patient Preference for Dexamethasone Intracanalicular Insert or Topical Prednisolone Acetate for Control of Postoperative Symptoms Following Bilateral Femtosecond Laser in Site Keratomileusis (LASIK)
por: Greenwood MD, et al.
Publicado: (2020) -
Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults
por: Blizzard C, et al.
Publicado: (2021) -
Long-Term Effect of Early Phacoemulsification in Primary Angle Closure Glaucoma Patients with Cataract: A 10-Year Follow-Up Study
por: Helmy H
Publicado: (2021) -
Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy
por: Suñer IJ, et al.
Publicado: (2021)